Logo

American Heart Association

  71
  0


Final ID:

Discussant: MUSIC-HFpEF

  • Kawana, Masataka  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Author Disclosures:
    Masataka Kawana: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):FANCL Corp.:Active (exists now) ; Advisor:Holosis Health:Active (exists now) ; Advisor:Cardiac RSK3 Inhibitors, LLC:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
ANSWER-HF: A Randomized Controlled Trial of Sacubitril/Valsartan Versus Enalapril in Patients with Chronic Chagas Cardiomyopathy and Reduced Ejection Fraction

Madrini Junior Vagner, Antunes Talita, Damiani Lucas, Jose Grupi Cesar, Mathias Junior Wilson, Lopes Renato, Ramires Felix, Ramos Souza Paulo, Fernandes Fabio, Maria Ianni Barbara, Silva Martins Alan, JadÁn Luzuriaga Georgina Del Cisne, Cardoso Barbosa Fonseca Keila, Ribeiro Orlando, Bispo Da Cruz Allecineia

Discussant: BioVAT-HF DZHK20

Wu Joseph, Margulies Kenneth

More abstracts from these authors:
Precision therapy for Genetic HCM: Cardiac Myosin Inhibitors

Kawana Masataka, Wilsbacher Lisa, Wheeler Matthew

You have to be authorized to contact abstract author. Please, Login
Not Available